The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 36, Issue 5, 2012, Pages 303-311

  Kavanagh, Pierce ^a   Grigoryev, Andrej ^b   Melnik, Aleksandra ^b   Simonov, Anton ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Bureau of Forensic Medical Expertise   (Russian Federation)

^c Chemical Toxicology Laboratory   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHOXYBENZOYL) 1 PENTYLINDOLE; INDOLE DERIVATIVE; KETONE; UNCLASSIFIED DRUG; 3-(4-METHOXYBENZOYL)-1-PENTYLINDOLE; BIOLOGICAL MARKER; CANNABINOID; STREET DRUG;

ADULT; ARTICLE; DEALKYLATION; DEMETHYLATION; DERIVATIZATION; DRUG INTOXICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYDROXYLATION; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLITE; OXIDATION; URINALYSIS; CHEMISTRY; METHODOLOGY; OXIDATION REDUCTION REACTION; SUBSTANCE ABUSE; URINE;

ADULT; BIOLOGICAL MARKERS; CANNABINOIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYLATION; INDOLES; MALE; OXIDATION-REDUCTION; STREET DRUGS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84865846893     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks032     Document Type: Article

References (27)

1. United Nations Office on Drugs and Crime (UNODC). Synthetic cannabinoids in herbal products. http://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf (accessed Jul. 10, 2011).
2. Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., Ferreirós, N. (2009) 'Spice' and other herbal blends: Harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832-837.
3. Lindigkeit, R., Boehme, A., Eiserloh, I., Lubbecke, M., Wiggermann, M., Ernst, L. et al. (2009) Spice: A never ending story? Forensic Science International, 191, 58-63.
4. Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., Goda, Y. (2010) Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International, 198, 31-38.
5. Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Goda, Y. (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicology, 27, 61-66.
6. Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Goda, Y. (2010) Schedules of controlled substances: Temporary placement of five synthetic cannabinoids into Schedule I. Federal Register, 75, 71635-71638.
7. Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., Auwärter, V. (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectrometry, 45, 1186-1194.
8. Nakajima, J., Takahashi, M., Seto, T., Suzuki, J. (2011) Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet. Forensic Toxicology, 29, 51-55.
9. Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y. (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicology, 29, 25-37.
10. Hudson, S., Ramsey, J. (2011) The emergence and analysis of synthetic cannabinoids. Drug Testing and Analysis, 3, 466-478.
11. Kneisel, S., Westphal, F., Rösner, P., Brecht, V., Ewald, A., Klein, B. et al. (2011) Cannabinoidmimetika: Massenspektren und IR-ATRSpektren neuer Verbindungen aus den Jahren 2009/2010. Toxichem Krimtech, 78, 23-35.
12. Nakajima, J., Takahashi, M., Seto, T., Kanai, C., Suzuki, J., Yoshida, M. et al. (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicology, 29, 95-110.
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annex 2 - New psychoactive substances reported to the EMCDDA and Europol for the first time in 2010 under the terms of Council Decision 2005/387/JHA. http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf. (accessed June 10, 2011).
14. Kavanagh, P., Spiers, P., O'Brien, J., McNamara, S., Angelov, D., Mullan, D. et al. Head shop 'legal highs' active constituents identification chart (July-Augist 2010, '714'-'823'). http://www.drugsandalcohol.ie/13972/1/Head_shops_identification_July_Aug_-2010.pdf (accessed Aug 12, 2010).
15. Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., Auwärter, V. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163-171.
16. Teske, J., Weller, J.P., Fieguth, A., Rothämel, T., Schulz, Y., Tröger, H.D. (2010) Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 878, 2959-2663.
17. Izotov, B.N., Savchuk, S.A., Grigoryev, A.M., Melnik, A.A., Nosyrev, A.E., Dzhurko, J.A. et al. (2011) Synthetic cannabinoids in the plant mixes 'Spice.' Identification of JWH-018 metabolites as use signs in the biological liquids of rats and humans. Narcology (Russian), 2, 73-83.
18. Grigoryev, A., Kavanagh, P., Melnik, A. (2011) The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography/mass spectrometry. Drug Testing and Analysis, November 18, 2011: 10.1002/dta.350.
19. Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., Rozhanets, V. (2011) Gas and liquid chromatography-mass spectrometry studies on the metabolism of synthetic phenylacetylindole cannabimimetic JWH-250, psychoactive components of smoking mixtures. Journal of Chromatography B, 879, 2519-2526.
20. Kraemer, T., Rust, K.Y., Meyer, M.R., Wissenbach, D.K., Bregel, D., Hopf, M. et al. (2009) Studies on the metabolism of JWH-018 and of a homologue of CP 47,497, pharmacologically active ingredients of different misused incense ('Spice') using GC-MS and LCMSn techniques. Annales de Toxicologie Analytique, 21, O43.
21. Sobolevsky, T., Prasolov, I., Rodchenkov, G. (2010) Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200, 141-147.
22. Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M. et al. (2011) Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography B, 879, 1126-1136.
23. Möller, I., Wintermeyer, A., Bender, K., Jübner, M., Thomas, A., Krug, O. et al. (2010) Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Testing and Analysis, 3, 609-620.
24. Beuck, S., Möller, I., Thomas, A., Klose, A., Schlörer, N., Schänzer, W. et al. (2011) Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Analytical and Bioanalytical Chemistry, 401, 493-505.
25. Zhang, Q., Ma, P., Cole, R.B., Wang, G. (2006) Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Analytical and Bioanalytical Chemistry, 386, 1345-1355.
26. Wintermeyer, A., Möller, I., Thevis, M., Jübner, M., Beike, J., Rothschild, M.A. et al. (2010) In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Analytical and Bioanalytical Chemistry, 398, 2141-2153.
27. Chimalakonda, K.C., Bratton, S.M., Le, V.-H., Yiew, K.H., Dineva, A., Moran, C.L. et al. (2011) Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human udp-glucuronosyltransferases. Drug Metabolism and Disposition, 39, 1967-1976.